S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
LON:MTPH

Midatech Pharma plc (MTPH.L) Share Forecast, Price & News

GBX 32.50
-0.50 (-1.52 %)
(As of 01/18/2021 09:00 PM ET)
Add
Compare
Today's Range
31.50
Now: GBX 32.50
35
50-Day Range
25
MA: GBX 27.10
32
52-Week Range
15
Now: GBX 32.50
87
Volume304,020 shs
Average Volume388,810 shs
Market Capitalization£20.50 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTD201, a long acting dose of Octreotide for the treatment of acromegaly and neuroendocrine tumors; and MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma. It also offers drug delivery platforms, such as Q-Sphera, a microencapsulation and polymer-depot sustained release drug delivery platform; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. Midatech Pharma plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Midatech Pharma plc (MTPH.L) logo

MarketRank

Overall MarketRank

0.66 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1235-841575
Employees65

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£390,000.00
Cash FlowGBX 10.83 per share
Book ValueGBX 11.60 per share

Profitability

Miscellaneous

Market Cap£20.50 million
Next Earnings DateN/A
OptionableNot Optionable
GBX 32.50
-0.50 (-1.52 %)
(As of 01/18/2021 09:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTPH News and Ratings via Email

Sign-up to receive the latest news and ratings for MTPH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Midatech Pharma plc (MTPH.L) (LON:MTPH) Frequently Asked Questions

How has Midatech Pharma plc (MTPH.L)'s stock price been impacted by Coronavirus (COVID-19)?

Midatech Pharma plc (MTPH.L)'s stock was trading at GBX 36 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MTPH shares have decreased by 12.5% and is now trading at GBX 31.50.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than Midatech Pharma plc (MTPH.L)?

Wall Street analysts have given Midatech Pharma plc (MTPH.L) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Midatech Pharma plc (MTPH.L) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Midatech Pharma plc (MTPH.L)'s earnings last quarter?

Midatech Pharma plc (MTPH.L) (LON:MTPH) issued its earnings results on Thursday, September, 10th. The company reported ($64.00) earnings per share (EPS) for the quarter.
View Midatech Pharma plc (MTPH.L)'s earnings history
.

Who are some of Midatech Pharma plc (MTPH.L)'s key competitors?

What other stocks do shareholders of Midatech Pharma plc (MTPH.L) own?

Who are Midatech Pharma plc (MTPH.L)'s key executives?

Midatech Pharma plc (MTPH.L)'s management team includes the following people:
  • Mr. Stephen A. Stamp, CEO, CFO & Director (Age 58, Pay $171.18k)
  • Dr. Tim Sparey Ph.D., Chief Bus. Officer
  • Mr. Justin Barry BSc (Hons.), MBIOL, CBIOL, QP, Head of Manufacturing
  • Dr. Steve Damment, Exec. VP of R&D (Age 62)
  • Mr. David Benharris, Pres of Midatech Pharma US Inc (Age 55)

What is Midatech Pharma plc (MTPH.L)'s stock symbol?

Midatech Pharma plc (MTPH.L) trades on the London Stock Exchange (LON) under the ticker symbol "MTPH."

How do I buy shares of Midatech Pharma plc (MTPH.L)?

Shares of MTPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Midatech Pharma plc (MTPH.L)'s stock price today?

One share of MTPH stock can currently be purchased for approximately GBX 31.50.

How big of a company is Midatech Pharma plc (MTPH.L)?

Midatech Pharma plc (MTPH.L) has a market capitalization of £19.87 million and generates £390,000.00 in revenue each year. Midatech Pharma plc (MTPH.L) employs 65 workers across the globe.

What is Midatech Pharma plc (MTPH.L)'s official website?

The official website for Midatech Pharma plc (MTPH.L) is www.midatechpharma.com.

How can I contact Midatech Pharma plc (MTPH.L)?

Midatech Pharma plc (MTPH.L)'s mailing address is 65 Innovation Drive, Milton Park, ABINGDON, OX14 4RQ, United Kingdom. The company can be reached via phone at +44-1235-841575.

This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.